Adagio Therapeutics Company

Adagio Therapeutics offers research and development of therapeutic pharmaceuticals related to COVID-19.


Investors

Funding Status: IPO
Headquarters: Waltham, Massachusetts, United States
Total Funding: 466000000
Founded Date: 2020-01-01
Industry: PharmTech
Last Funding Type: Series C
Employee Number: 11-50